Recurrent Childhood Acute Lymphoblastic Leukemia Not Yet Recruiting Phase 1 Trials for DB01073 (Fludarabine)

IndicationStatusPhase
DBCOND0028597 (Recurrent Childhood Acute Lymphoblastic Leukemia)Not Yet Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03326921HA-1 T TCR T Cell Immunotherapy for the Treating of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell TransplantTreatment